Takoua Kaaouana

Learn More
Cerebral microbleeds (CMBs) have emerged as a new imaging marker of small vessel disease. Composed of hemosiderin, CMBs are paramagnetic and can be detected with MRI sequences sensitive to magnetic susceptibility (typically, gradient recalled echo T2* weighted images). Nevertheless, their identification remains challenging on T2* magnitude images because of(More)
INTRODUCTION/PURPOSE In vivo detection of cerebral microbleeds (CMBs) from T2* gradient recalled echo (GRE) magnitude image suffers from low specificity, modest inter-rater reproducibility and is biased by its sensitivity to acquisition parameters. New methods were proposed for improving this identification, but they mostly rely on 3D acquisitions, not(More)
Brain microbleeds (BMBs) have emerged as a new imaging marker of small vessel diseases and they may play a crucial role in degenerative pathology such as Alzheimer's disease. Composed of hemosiderin, BMBs can be efficiently detected with MRI sequences sensitive to magnetic susceptibility (e.g. gradient recalled echo T2*W images). Nevertheless, that(More)
  • 1